Follow
Christopher Rovera
Christopher Rovera
INSERM, PhD student, Université Côte d'Azur
No verified email
Title
Cited by
Cited by
Year
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma
I Berestjuk, M Lecacheur, A Carminati, S Diazzi, C Rovera, V Prod’homme, ...
EMBO Molecular Medicine 14 (2), e11814, 2022
352022
Secretion of IL1 by dedifferentiated melanoma cells inhibits JAK1-STAT3–driven actomyosin contractility of lymph node fibroblastic reticular cells
C Rovera, I Berestjuk, M Lecacheur, C Tavernier, S Diazzi, S Pisano, ...
Cancer Research 82 (9), 1774-1788, 2022
142022
Targeting DDR1 and DDR2 overcomes matrix-mediated melanoma cell adaptation to BRAF-targeted therapy
I Berestjuk, M Lecacheur, S Diazzi, C Rovera, V Prod’Homme, ...
bioRxiv, 857896, 2019
32019
Invasive dedifferentiated melanoma cells inhibit JAK1-STAT3-driven actomyosin contractility of human fibroblastic reticular cells of the lymph node
C Rovera, I Berestjuk, M Lecacheur, S Diazzi, A Mallavialle, J Albrengues, ...
bioRxiv, 2021.03. 25.436913, 2021
2021
Étude des propriétés contractiles des fibroblastes du ganglion lymphatique au cours de la mise en place de la niche pré-métastatique du mélanome
C Rovera
Université Côte d'Azur, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–5